Shanghai Epidemiology Study for Adolescents and Children With Cancer

Childhood Cancer Clinical Trial

Official title:

Shanghai Epidemiology Study for Adolescents and Children With Cancer

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02959086
• Other study ID #: CCGChina
• Status: Recruiting
• Start date: January 2002
• Est. completion date: January 2030

Study information

• Verified date: February 2024
• Source: Children's Cancer Group, China
• Contact: Yi-Jin Gao, MD
• Phone: 0086-21-38626161
• Email: gaoyijin[@]scmc.com.cn
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.

Description:

The investigators collected information of all the adolescents and children diagnosed cancer in Shanghai since January 2002, including their name, gender, the date of birth, the diagnosis date, disease diagnosis, residence address and the last follow-up time status (survival/death). The type of cancer included all malignant tumors such as Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, central nervous system tumors, Neuroblastoma, Wilms tumor and so on. Then the investigators would analyze the morbidity, mortality, disability and survival rate.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2000
• Est. completion date: January 2030
• Est. primary completion date: April 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 0 Years to 19 Years

Eligibility

Inclusion Criteria:

• 0-19 year-old children and adolescents.

• Diagnosed cancer in Shanghai since January 2002.

Exclusion Criteria:

• Patients who were lost of follow-up.

• Patient's death wasn't caused by cancer or complications but by other accidents such as car accident, fell from a great height and so on.

Related Conditions & MeSH terms

• Childhood Cancer

Locations

Country	Name	City	State
China	Shanghai Children's Medical Center	Shanghai	Shanghai
China	Shanghai Municipal Center of Disease Prevention & Control	Shanghai	Shanghai

Sponsors (3)

Lead Sponsor	Collaborator
Children's Cancer Group, China	Shanghai Children's Medical Center, Shanghai Municipal Center for Disease Prevention & Control

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Disability rate for the whole cohort		5 years
Primary	Overall survival for the whole cohort		5 years
Secondary	Mortality for the whole cohort		5 years